Huntington’s Disease Therapeutics Conference 2016 – day 1
By Dr Ed Wild on February 25, 2016, Edited by Dr Jeff Carroll If it’s February, that means the the
Read more.
Could a new “jaw-dropping” breakthrough help treat Huntington’s Disease?
Recent days have seen a torrent of news stories about a new technology, called CRISPR, which has been described as
Read more.
The link between sleep disturbance and Huntingtons Disease
A review published in the journal Nature and Science of Sleep explores the links between sleep disturbance and neurodegeneration in
Read more.
IBM Researchers’ new approach could result in a breakthrough in Huntington’s treatment
Disruption in brain dynamics could underlie the pathophysiology of Huntington’s disease In 2011, IBM neuroscientists unveiled the Neural Tissue Simulator, a
Read more.
1 in 3 Europeans fit under the umbrella – do you?
‘Together Under the Umbrella’ is an innovative campaign which will launch during Brain Awareness Week, March 2016. A year-long initiative
Read more.
Light shed on molecular mechanisms of Huntington’s
News-medical.net have reported that researchers at the University of Pittsburgh School of Medicine have shown that the core of the
Read more.
Harnessing the power of viruses to treat Huntington’s disease
Researchers design a virus to more effectively deliver gene-silencing drugs throughout the brain New therapies for disorders like Huntington’s disease
Read more.
Through a Broader Lens: Looking at Non-Motor Symptoms in HD
Common depictions of HD emphasizing only its movement symptoms paint an incomplete picture of the real disease. HD causes both
Read more.
Looking Past the Spin: Results from a Clinical Trial of Cysteamine
In early December, Raptor Pharmaceuticals released clinical trial results evaluating a drug called cysteamine in Huntington’s disease. News headlines about
Read more.